Are you struggling with the discomfort and inconvenience of Benign Prostatic Hyperplasia (BPH)? Optilume BPH offers a cutting-edge, minimally invasive solution that goes beyond traditional treatments. Discover how this FDA-approved procedure can enhance your quality of life.
Optilume BPH: A Minimally Invasive Breakthrough
The Optilume is an inventive approach to BPH treatment. It is a minimally invasive FDA approved BPH procedure that uses a drug-coated balloon to expand the prostatic channel. Once inserted through the urethra via a cystoscope, and placed in the prostate, the ballon is inflated, releasing and transferring the drug (Paclitaxel) to the tissue. Expansion of the balloon creates a large open channel and the drug prevents regrowth of the prostatic tissue. This combination maintains long term patency. The Optilume device offers surgical results with reduced side effects.